GDRX
Income statement / Annual
Last year (2023), GoodRx Holdings, Inc.'s total revenue was $750.27 M,
a decrease of 2.12% from the previous year.
In 2023, GoodRx Holdings, Inc.'s net income was -$8.87 M.
See GoodRx Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$750.27 M
|
$766.55 M
|
$745.42 M
|
$550.70 M
|
$388.22 M
|
$249.52 M
|
$157.24 M
|
$99.38 M
|
| Cost of Revenue |
$66.93 M |
$65.08 M |
$46.72 M |
$29.59 M |
$14.02 M |
$6.04 M |
$12.17 M |
$10.32 M |
| Gross Profit |
$683.34 M |
$701.48 M |
$698.71 M |
$521.11 M |
$374.21 M |
$243.49 M |
$145.07 M |
$89.06 M |
| Gross Profit Ratio |
0.91 |
0.92 |
0.94 |
0.95 |
0.96 |
0.98 |
0.92 |
0.9 |
| Research and Development
Expenses |
$135.84 M
|
$143.14 M
|
$125.86 M
|
$61.82 M
|
$29.30 M
|
$43.89 M
|
$11.50 M
|
$5.74 M
|
| General & Administrative
Expenses |
$125.52 M
|
$144.79 M
|
$154.69 M
|
$461.45 M
|
$14.69 M
|
$8.36 M
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$341.33 M
|
$357.63 M
|
$370.22 M
|
$255.14 M
|
$176.97 M
|
$104.18 M
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$466.84 M
|
$502.42 M
|
$524.90 M
|
$716.59 M
|
$191.66 M
|
$112.54 M
|
$83.26 M
|
$64.40 M
|
| Other Expenses |
$107.67 M |
$54.18 M |
$34.54 M |
$18.43 M |
$13.57 M |
-$7,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$710.35 M |
$699.74 M |
$685.30 M |
$796.83 M |
$234.53 M |
$166.24 M |
$94.76 M |
$70.14 M |
| Cost And Expenses |
$777.27 M |
$764.82 M |
$732.02 M |
$826.42 M |
$248.55 M |
$172.27 M |
$106.93 M |
$80.46 M |
| Interest Income |
$32.17 M |
$9.27 M |
$59,000.00 |
$160,000.00 |
$715,000.00 |
$154,000.00 |
$24,000.00 |
$21,000.00 |
| Interest Expense |
$56.73 M |
$34.24 M |
$23.64 M |
$27.91 M |
$49.57 M |
$22.19 M |
$6.97 M |
$3.54 M |
| Depreciation &
Amortization |
$107.67 M
|
$57.53 M
|
$37.64 M
|
$22.91 M
|
$15.72 M
|
$9.81 M
|
$9.10 M
|
$9.09 M
|
| EBITDA |
$108.82 M
|
$68.54 M
|
$48.00 M
|
-$257.11 M
|
$148.27 M
|
$84.35 M
|
$59.41 M
|
$28.01 M
|
| EBITDA Ratio |
0.15 |
0.09 |
0.06 |
-0.47 |
0.39 |
0.35 |
0.38 |
0.28 |
| Operating Income Ratio
|
-0.04
|
0.01
|
0.02
|
-0.5
|
0.36
|
0.31
|
0.32
|
0.19
|
| Total Other
Income/Expenses Net |
-$28.57 M
|
-$24.97 M
|
-$23.58 M
|
-$27.73 M
|
-$56.70 M
|
-$24.90 M
|
-$10.60 M
|
-$3.82 M
|
| Income Before Tax |
-$55.57 M |
-$23.23 M |
-$10.18 M |
-$303.45 M |
$82.98 M |
$52.35 M |
$39.70 M |
$15.10 M |
| Income Before Tax Ratio
|
-0.07
|
-0.03
|
-0.01
|
-0.55
|
0.21
|
0.21
|
0.25
|
0.15
|
| Income Tax Expense |
-$46.70 M |
$9.60 M |
$15.08 M |
-$9.83 M |
$16.93 M |
$8.56 M |
$10.93 M |
$6.19 M |
| Net Income |
-$8.87 M |
-$32.83 M |
-$25.25 M |
-$293.62 M |
$66.05 M |
$43.79 M |
$8.84 M |
-$7.77 M |
| Net Income Ratio |
-0.01 |
-0.04 |
-0.03 |
-0.53 |
0.17 |
0.18 |
0.06 |
-0.08 |
| EPS |
-0.0216 |
-0.0795 |
-0.063 |
-0.75 |
0.11 |
0.12 |
0.0229 |
-0.0202 |
| EPS Diluted |
-0.0216 |
-0.0795 |
-0.063 |
-0.75 |
0.11 |
0.12 |
0.0229 |
-0.0202 |
| Weighted Average Shares
Out |
$410.32 M
|
$412.86 M
|
$400.56 M
|
$391.66 M
|
$385.38 M
|
$356.07 M
|
$385.38 M
|
$385.38 M
|
| Weighted Average Shares
Out Diluted |
$410.32 M
|
$412.86 M
|
$400.56 M
|
$391.66 M
|
$385.38 M
|
$362.60 M
|
$385.38 M
|
$385.38 M
|
| Link |
|
|
|
|
|
|
|
|
